Skip to main content
Premium Trial:

Request an Annual Quote

Halo Genomics and Life Tech Sign Co-Marketing Agreement

Premium

This story was originally published on April 7.

Halo Genomics has signed an agreement with Life Technologies to co-market its target enrichment kits with Life Tech's SOLiD system, the company said this week.

According to Halo, its products "fit well" with the Library Building benchtop device for automated library preparation for the SOLiD that Life Tech plans to launch soon.

"Halo Genomics' technology provides superior specificity and uniform coverage," Mark Gardner, vice president of Life Technologies, said in a statement.

Based in Uppsala, Sweden, Halo Genomics offers target enrichment kits and services for next-gen sequencing, based on its Selector technology (IS 3/1/2011).

Last month, the firm launched the HaloPlex PCR Reagent Kit, which allows users to amplify up to 2,000 exons in a single tube and includes library preparation for next-gen sequencing.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.